chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Blood bicarbonate increased, Blood fibrinogen increased, Blood gases abnormal, Blood pH increased, COVID-19
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/29, Pfizer, dose #1 02/19, Pfizer, dose #2 08/11 COVID swab, result: detected 08/11 pt cc: exposure: unknown 08/11 CXR impression: Peripheral airspace disease. Correlate clinically for pneumonia, including viral/atypical etiology and follow-up to resolution. 08/12 pt admitted to hospital dx: COVID 19 PNEUMONIA LOC: 2 DAYS 08/12 FIBRINOGEN result: 541 08/12 DDIMER result: <0.22 08/14 ESR result 26 08/12 SARS-COV-2 IgG result: 0.01 08/12 abg: i-pH result 7.48, i-PCO2 38.7, i-PO2 74, i-HCO3 28.5 08/12 strep pneumoniae antigen result: negative 08/12 legionella antigen, urine result: negative 08/12 quantiferon-tb result: negative 08/12 SARS-COV-2 TOTAL AB SPIKE result: >2500 08/13 FIBRINOGEN result: 503 08/13 DDIMER result: <0.22 08/13 ESR result 54 08/14 FIBRINOGEN result: 459 08/14 DDIMER result: <0.22 08/14 ESR result 61 09/20 CT CHEST Impression: 1. Nonspecific pleural thickening has resolved. Pulmonary nodules, recommend follow up with full inspiration chest CT scan in 12 months. Other findings as above.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Chest X-ray abnormal, Computerised tomogram thorax abnormal, Fibrin D dimer, Laboratory test normal
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/29, Pfizer, dose #1 02/19, Pfizer, dose #2 08/11 COVID swab, result: detected 08/11 pt cc: exposure: unknown 08/11 CXR impression: Peripheral airspace disease. Correlate clinically for pneumonia, including viral/atypical etiology and follow-up to resolution. 08/12 pt admitted to hospital dx: COVID 19 PNEUMONIA LOC: 2 DAYS 08/12 FIBRINOGEN result: 541 08/12 DDIMER result: <0.22 08/14 ESR result 26 08/12 SARS-COV-2 IgG result: 0.01 08/12 abg: i-pH result 7.48, i-PCO2 38.7, i-PO2 74, i-HCO3 28.5 08/12 strep pneumoniae antigen result: negative 08/12 legionella antigen, urine result: negative 08/12 quantiferon-tb result: negative 08/12 SARS-COV-2 TOTAL AB SPIKE result: >2500 08/13 FIBRINOGEN result: 503 08/13 DDIMER result: <0.22 08/13 ESR result 54 08/14 FIBRINOGEN result: 459 08/14 DDIMER result: <0.22 08/14 ESR result 61 09/20 CT CHEST Impression: 1. Nonspecific pleural thickening has resolved. Pulmonary nodules, recommend follow up with full inspiration chest CT scan in 12 months. Other findings as above.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Legionella test, Lung disorder, PCO2 normal, PO2 decreased, Pleural thickening
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/29, Pfizer, dose #1 02/19, Pfizer, dose #2 08/11 COVID swab, result: detected 08/11 pt cc: exposure: unknown 08/11 CXR impression: Peripheral airspace disease. Correlate clinically for pneumonia, including viral/atypical etiology and follow-up to resolution. 08/12 pt admitted to hospital dx: COVID 19 PNEUMONIA LOC: 2 DAYS 08/12 FIBRINOGEN result: 541 08/12 DDIMER result: <0.22 08/14 ESR result 26 08/12 SARS-COV-2 IgG result: 0.01 08/12 abg: i-pH result 7.48, i-PCO2 38.7, i-PO2 74, i-HCO3 28.5 08/12 strep pneumoniae antigen result: negative 08/12 legionella antigen, urine result: negative 08/12 quantiferon-tb result: negative 08/12 SARS-COV-2 TOTAL AB SPIKE result: >2500 08/13 FIBRINOGEN result: 503 08/13 DDIMER result: <0.22 08/13 ESR result 54 08/14 FIBRINOGEN result: 459 08/14 DDIMER result: <0.22 08/14 ESR result 61 09/20 CT CHEST Impression: 1. Nonspecific pleural thickening has resolved. Pulmonary nodules, recommend follow up with full inspiration chest CT scan in 12 months. Other findings as above.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary mass, Red blood cell sedimentation rate increased, SARS-CoV-2 antibody test, SARS-CoV-2 test positive, Streptococcus test negative
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/29, Pfizer, dose #1 02/19, Pfizer, dose #2 08/11 COVID swab, result: detected 08/11 pt cc: exposure: unknown 08/11 CXR impression: Peripheral airspace disease. Correlate clinically for pneumonia, including viral/atypical etiology and follow-up to resolution. 08/12 pt admitted to hospital dx: COVID 19 PNEUMONIA LOC: 2 DAYS 08/12 FIBRINOGEN result: 541 08/12 DDIMER result: <0.22 08/14 ESR result 26 08/12 SARS-COV-2 IgG result: 0.01 08/12 abg: i-pH result 7.48, i-PCO2 38.7, i-PO2 74, i-HCO3 28.5 08/12 strep pneumoniae antigen result: negative 08/12 legionella antigen, urine result: negative 08/12 quantiferon-tb result: negative 08/12 SARS-COV-2 TOTAL AB SPIKE result: >2500 08/13 FIBRINOGEN result: 503 08/13 DDIMER result: <0.22 08/13 ESR result 54 08/14 FIBRINOGEN result: 459 08/14 DDIMER result: <0.22 08/14 ESR result 61 09/20 CT CHEST Impression: 1. Nonspecific pleural thickening has resolved. Pulmonary nodules, recommend follow up with full inspiration chest CT scan in 12 months. Other findings as above.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Narrative:  Breakthrough COVID infection requiring hospitalization
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: Narrative:  Patient admitted for severe case of COVID-19 despite being receiving both vaccines in the series on 03/10/2021 and 04/07/2021.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Chest X-ray normal, Constipation
Clinical narrative: Narrative:  Fully vaccinated patient admitted from LTC facility for acute hypoxic respiratory failure secondary to COVID-19 pneumonia with sepsis on 08/20/21. For COVID-19, received dexamethasone and remdesivir. Admitted with leg pain and swelling that improved on its own over the hospital course (on chronic warfarin). Had diarrhea on admission, constipation during hospitalization and normal BM on discharge. Treated empirically for bacterial pneumonia (ceftriaxone/azithromycin). Cough and SOB reported throughout admission. Ipratropium added, albuterol changed from PRN to scheduled to target respiratory symptoms. Initially on heated high flow oxygen due to tachypnea and SOB but on room air during/upon discharge. SOB improved. Cough persisted (despite antitussives and resumption of home furosemide). Repeat chest xray without overt heart failure and no acute process. Stable at discharge (8/31/21) Transferred back to care facility. Received notice after discharge patient dies 9/1/21. Cause of death unknown at this time; autopsy planned.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Death, Diarrhoea, Dyspnoea, Pain in extremity
Clinical narrative: Narrative:  Fully vaccinated patient admitted from LTC facility for acute hypoxic respiratory failure secondary to COVID-19 pneumonia with sepsis on 08/20/21. For COVID-19, received dexamethasone and remdesivir. Admitted with leg pain and swelling that improved on its own over the hospital course (on chronic warfarin). Had diarrhea on admission, constipation during hospitalization and normal BM on discharge. Treated empirically for bacterial pneumonia (ceftriaxone/azithromycin). Cough and SOB reported throughout admission. Ipratropium added, albuterol changed from PRN to scheduled to target respiratory symptoms. Initially on heated high flow oxygen due to tachypnea and SOB but on room air during/upon discharge. SOB improved. Cough persisted (despite antitussives and resumption of home furosemide). Repeat chest xray without overt heart failure and no acute process. Stable at discharge (8/31/21) Transferred back to care facility. Received notice after discharge patient dies 9/1/21. Cause of death unknown at this time; autopsy planned.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling, Pneumonia bacterial, SARS-CoV-2 test positive, Sepsis, Tachypnoea
Clinical narrative: Narrative:  Fully vaccinated patient admitted from LTC facility for acute hypoxic respiratory failure secondary to COVID-19 pneumonia with sepsis on 08/20/21. For COVID-19, received dexamethasone and remdesivir. Admitted with leg pain and swelling that improved on its own over the hospital course (on chronic warfarin). Had diarrhea on admission, constipation during hospitalization and normal BM on discharge. Treated empirically for bacterial pneumonia (ceftriaxone/azithromycin). Cough and SOB reported throughout admission. Ipratropium added, albuterol changed from PRN to scheduled to target respiratory symptoms. Initially on heated high flow oxygen due to tachypnea and SOB but on room air during/upon discharge. SOB improved. Cough persisted (despite antitussives and resumption of home furosemide). Repeat chest xray without overt heart failure and no acute process. Stable at discharge (8/31/21) Transferred back to care facility. Received notice after discharge patient dies 9/1/21. Cause of death unknown at this time; autopsy planned.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Chest X-ray abnormal, Chronic obstructive pulmonary disease, Clostridium difficile infection
Clinical narrative: Narrative: Admission Date: Sep 23,2021 Discharge: Sep 8,2021 Condition of patient at discharge: deceased Acute hypoxic respiratory failure secondary to COVID-19 complicated by COPD on home O2. 73 year old male PMHx of COPD (on 3.5-4L NC baseline), HFpEF, saddle pulmonary embolism (s/p IVC filter), OSA, HTN, gout, and hyperlipidemia, presented to the Emergency Dept with dyspnea, found to be COVID+ (8/23) and worsening acute hypoxic respiratory failure despite being vaccinated with Janssen (J&J) vaccine on 5/11/2021. Patient treated for Covid (see treatment meds), pneumonia (vancomycin and Zosyn) and C. difficile (oral vancomycin) while hospitalized. Continued to require high flow nasal cannula and unable to wean off. Discussions had with family and patient for comfort care only with morphine for air hunger. Patient unfortunately passed away on 9/8/21.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Death, Dyspnoea, Lung disorder, Pneumonia
Clinical narrative: Narrative: Admission Date: Sep 23,2021 Discharge: Sep 8,2021 Condition of patient at discharge: deceased Acute hypoxic respiratory failure secondary to COVID-19 complicated by COPD on home O2. 73 year old male PMHx of COPD (on 3.5-4L NC baseline), HFpEF, saddle pulmonary embolism (s/p IVC filter), OSA, HTN, gout, and hyperlipidemia, presented to the Emergency Dept with dyspnea, found to be COVID+ (8/23) and worsening acute hypoxic respiratory failure despite being vaccinated with Janssen (J&J) vaccine on 5/11/2021. Patient treated for Covid (see treatment meds), pneumonia (vancomycin and Zosyn) and C. difficile (oral vancomycin) while hospitalized. Continued to require high flow nasal cannula and unable to wean off. Discussions had with family and patient for comfort care only with morphine for air hunger. Patient unfortunately passed away on 9/8/21.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: Admission Date: Sep 23,2021 Discharge: Sep 8,2021 Condition of patient at discharge: deceased Acute hypoxic respiratory failure secondary to COVID-19 complicated by COPD on home O2. 73 year old male PMHx of COPD (on 3.5-4L NC baseline), HFpEF, saddle pulmonary embolism (s/p IVC filter), OSA, HTN, gout, and hyperlipidemia, presented to the Emergency Dept with dyspnea, found to be COVID+ (8/23) and worsening acute hypoxic respiratory failure despite being vaccinated with Janssen (J&J) vaccine on 5/11/2021. Patient treated for Covid (see treatment meds), pneumonia (vancomycin and Zosyn) and C. difficile (oral vancomycin) while hospitalized. Continued to require high flow nasal cannula and unable to wean off. Discussions had with family and patient for comfort care only with morphine for air hunger. Patient unfortunately passed away on 9/8/21.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Cough, Oropharyngeal pain
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/14, Pfizer, dose #1 02/04, Pfizer, dose #2 08/31 pt cc: cough, loss of taste or smell, sore throat exposure: unknown 09/02 COVID swab, result detected
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/14, Pfizer, dose #1 02/04, Pfizer, dose #2 08/31 pt cc: cough, loss of taste or smell, sore throat exposure: unknown 09/02 COVID swab, result detected
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Pneumonia, Sepsis
Clinical narrative: Narrative:  Patient admitted for pneumonia due to coronavirus disease 2019; other specified sepsis; acute respiratory failure with hypoxia
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Narrative:  Breakthrough COVID infection requiring hospitalization
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Anticoagulant therapy, Atrial fibrillation, COVID-19, Cardiac failure, Cough
Clinical narrative: Narrative:  62 year old obese male admitted 8/19/2021 for the treatment of atrial fibrillation w/ RVR and HF exacerbation. He was found to have COVID symptoms 8/26/2021, including a fever and cough. COVID test returned positive 8/26/2021 despite being fully vaccinated with Moderna COVID vaccine on 1/8/2021 and 2/5/2021. PMH: HTN, CAD, PTSD, severe depression, ETOH dependence, hiatal hernia, barret's esophagus, GIST tumor (on Gleevec,) h/o GI bleed, gout, AF with prior MAZE 2018 & AF ablation 10/2017 and numerous prior cardioversions, mitraclip 2018, CAD s/p 3vCABG 2018, HF (EF 59%, but previously as low as 39%). Typically monoclonal antibodies are reserved for outpatients, but patient is hospitalized for a reason not related to COVID-19 and meets criteria for infusion at this time. Patient is eligible to receive an COVID-19 monoclonal antibody infusion to prevent progression of condition. Patient is considered at high risk for progression to severe disease based on risk factors identified above. Patient was offered a monoclonal antibody infusion and accepted. The Regeneron product was given 8/26/201. Given increasing O2 requirement and fever and elevated d-Dimer, patient also began remdesivir on 8/28/2021. Anticoagulation with enoxaparin 1 mg/kg q12h was also begun. He was discharged in stable condition on 9/11/2021.
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fibrin D dimer increased, Malaise, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative:  62 year old obese male admitted 8/19/2021 for the treatment of atrial fibrillation w/ RVR and HF exacerbation. He was found to have COVID symptoms 8/26/2021, including a fever and cough. COVID test returned positive 8/26/2021 despite being fully vaccinated with Moderna COVID vaccine on 1/8/2021 and 2/5/2021. PMH: HTN, CAD, PTSD, severe depression, ETOH dependence, hiatal hernia, barret's esophagus, GIST tumor (on Gleevec,) h/o GI bleed, gout, AF with prior MAZE 2018 & AF ablation 10/2017 and numerous prior cardioversions, mitraclip 2018, CAD s/p 3vCABG 2018, HF (EF 59%, but previously as low as 39%). Typically monoclonal antibodies are reserved for outpatients, but patient is hospitalized for a reason not related to COVID-19 and meets criteria for infusion at this time. Patient is eligible to receive an COVID-19 monoclonal antibody infusion to prevent progression of condition. Patient is considered at high risk for progression to severe disease based on risk factors identified above. Patient was offered a monoclonal antibody infusion and accepted. The Regeneron product was given 8/26/201. Given increasing O2 requirement and fever and elevated d-Dimer, patient also began remdesivir on 8/28/2021. Anticoagulation with enoxaparin 1 mg/kg q12h was also begun. He was discharged in stable condition on 9/11/2021.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Blood fibrinogen increased, COVID-19, COVID-19 pneumonia, Chest X-ray normal
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/16, Pfizer, dose #1 03/09, Pfizer, dose #2 08/03 pt cc: cough, fatigue, dyspnea, exposure: unknown 08/09 COVID swab, result: detected 08/09 EKG: 93005: NSR 88, N-axis, no stemi 08/09 pt admit ED dx: ACUTE HYPOXEMIC RESPIRATORY FAILURE 2/2 COVID-19 PNEUMONIA loc: 10 days 08/09 FIBRINOGEN 440 mg/dL 214 - 489 [67] 08/09 DDIMER 0.43 mcg/mL 0.27 - 0.49 [67] 08/09 TROPONIN I <0.016 ng/,mL Ref: <=0.031 [67] 08/09 CXR: impression: No acute cardiopulmonary abnormality or significant change since August 2020. 08/09 CT chest w/o: impression: 1. Bilateral patchy foci of groundglass opacity is pronounced in the lower lobes, consistent with COVID-19 pneumonia. 2. Hepatic steatosis with probable hepatomegaly. 3. Small hiatal hernia.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram thorax abnormal, Cough, Dyspnoea, Electrocardiogram, Fatigue
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/16, Pfizer, dose #1 03/09, Pfizer, dose #2 08/03 pt cc: cough, fatigue, dyspnea, exposure: unknown 08/09 COVID swab, result: detected 08/09 EKG: 93005: NSR 88, N-axis, no stemi 08/09 pt admit ED dx: ACUTE HYPOXEMIC RESPIRATORY FAILURE 2/2 COVID-19 PNEUMONIA loc: 10 days 08/09 FIBRINOGEN 440 mg/dL 214 - 489 [67] 08/09 DDIMER 0.43 mcg/mL 0.27 - 0.49 [67] 08/09 TROPONIN I <0.016 ng/,mL Ref: <=0.031 [67] 08/09 CXR: impression: No acute cardiopulmonary abnormality or significant change since August 2020. 08/09 CT chest w/o: impression: 1. Bilateral patchy foci of groundglass opacity is pronounced in the lower lobes, consistent with COVID-19 pneumonia. 2. Hepatic steatosis with probable hepatomegaly. 3. Small hiatal hernia.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Fibrin D dimer increased, Hepatic steatosis, Hepatomegaly, Lung opacity, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/16, Pfizer, dose #1 03/09, Pfizer, dose #2 08/03 pt cc: cough, fatigue, dyspnea, exposure: unknown 08/09 COVID swab, result: detected 08/09 EKG: 93005: NSR 88, N-axis, no stemi 08/09 pt admit ED dx: ACUTE HYPOXEMIC RESPIRATORY FAILURE 2/2 COVID-19 PNEUMONIA loc: 10 days 08/09 FIBRINOGEN 440 mg/dL 214 - 489 [67] 08/09 DDIMER 0.43 mcg/mL 0.27 - 0.49 [67] 08/09 TROPONIN I <0.016 ng/,mL Ref: <=0.031 [67] 08/09 CXR: impression: No acute cardiopulmonary abnormality or significant change since August 2020. 08/09 CT chest w/o: impression: 1. Bilateral patchy foci of groundglass opacity is pronounced in the lower lobes, consistent with COVID-19 pneumonia. 2. Hepatic steatosis with probable hepatomegaly. 3. Small hiatal hernia.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Troponin I normal
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/16, Pfizer, dose #1 03/09, Pfizer, dose #2 08/03 pt cc: cough, fatigue, dyspnea, exposure: unknown 08/09 COVID swab, result: detected 08/09 EKG: 93005: NSR 88, N-axis, no stemi 08/09 pt admit ED dx: ACUTE HYPOXEMIC RESPIRATORY FAILURE 2/2 COVID-19 PNEUMONIA loc: 10 days 08/09 FIBRINOGEN 440 mg/dL 214 - 489 [67] 08/09 DDIMER 0.43 mcg/mL 0.27 - 0.49 [67] 08/09 TROPONIN I <0.016 ng/,mL Ref: <=0.031 [67] 08/09 CXR: impression: No acute cardiopulmonary abnormality or significant change since August 2020. 08/09 CT chest w/o: impression: 1. Bilateral patchy foci of groundglass opacity is pronounced in the lower lobes, consistent with COVID-19 pneumonia. 2. Hepatic steatosis with probable hepatomegaly. 3. Small hiatal hernia.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Aspiration, Death, Dysphagia
Clinical narrative: Narrative:  75y.o. MALE with a h/o HTN, DM2, Obesity, Vertigo/Tinnitus, Parkinson's vs. progressive supranuclear palsy, HLD, Lumbar spine stenosis, CAD s/p CABG, and BPH w/ LUTs who died in nursing home (in hospice care) from dysphagia and aspiration. Pt had received covid vaccines on 2/23/21 and 3/22/21. This death is likely not related to the vaccinations due to comorbidities, age, and length of time from vaccine administration.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: C-reactive protein increased, COVID-19, Cough, Exposure to SARS-CoV-2, Hypoxia
Clinical narrative: Narrative:  COVID positive hospitalization following completion of Pfizer vaccine series
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Oxygen saturation decreased, Pyrexia, Renal impairment, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID positive hospitalization following completion of Pfizer vaccine series
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Narrative:  Breakthrough Delta Variant COVID infection requiring hospitalization
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Death, Sepsis
Clinical narrative: Narrative:  Patient admitted for pneumonia due to coronavirus disease 2019; other specified sepsis; acute respiratory failure with hypoxia. Patient passed away in 08/15/2021
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Narrative:  Breakthrough Covid-19 infection
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccine breakthrough infection
Clinical narrative: Narrative:  Breakthrough case requiring the patient to be hospitalized
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Bacteraemia, Bladder catheterisation, Death, Intentional medical device removal by patient, Lethargy
Clinical narrative: Narrative:  Pt is a 92 YO male who was admitted to the hospital for pulling out his foley catheter. Pt had a PMH of Dementia, CKD stage IIIb, persistent afib without RVR, HTN, T2DM on insulin, CAD, hypothyroidism, anemia, hx of folate and vitamin D deficiency, urothelial carcinoma of bladder s/p TUR of bladder tumor in 2019, and recent hospitalization for UTI. Pt continued to receive treatment for UTI and bacteremia. Pt became lethargic and began having decreased O2 requirements; subsequently, family agreed to transfer to hospice. Pt passed away.
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: Narrative:  Pt is a 92 YO male who was admitted to the hospital for pulling out his foley catheter. Pt had a PMH of Dementia, CKD stage IIIb, persistent afib without RVR, HTN, T2DM on insulin, CAD, hypothyroidism, anemia, hx of folate and vitamin D deficiency, urothelial carcinoma of bladder s/p TUR of bladder tumor in 2019, and recent hospitalization for UTI. Pt continued to receive treatment for UTI and bacteremia. Pt became lethargic and began having decreased O2 requirements; subsequently, family agreed to transfer to hospice. Pt passed away.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac failure acute, Condition aggravated, Death, Left ventricular failure
Clinical narrative: Narrative:  82yo male discharged to outpt hospice with discharge diagnosis of Acute on chronic systolic HF exacerbation. on 9/9/2021. Pt died at home in home hospice on 9/12/2021. Pt had one covid vaccine on 3/19/2021. This death is likely not related to the vaccination due to comorbidities, age, and length of time from vaccine administration.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cellulitis, Chronic obstructive pulmonary disease, Death, Urinary retention
Clinical narrative: Narrative:  Per notes, Patient received COVID #1 on 6/8/21 and COVID #2 on 7/6/21 in the community. Vaccine card with additional details is not available to me at this time. On 7/28/21, he was admitted to a non agency facility with c/o lower extremity cellulitis and urinary retention. He remained in that facility until 8/3/21 when he discharged home. On 8/4/21, the agency approved home hospice for Patient due to end stage COPD. He passed away on 8/8/21. No autopsy reports available. There were 33 days from time of second vaccine until date of death.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  74yo male patient with diagnosis of end stage renal disease on dialysis with history of noncompliance with dialysis visits and has missed up to 1-2 weeks at a time even though has been educated on the importance of routine dialysis has died on 8/11/2021 with no hospitalizations and no notes regarding pt's death. Pt had covid vaccines on 5/28/21 & 3/31/21. Pt's PROBLEM LIST: Diabetes HTN Hyperlipidemia CKD 5 COPD BPH PTSD Anemia Restless legs Gout Low back pain This death is likely not related to the vaccinations due to comorbidities, age, and length of time from vaccine administration.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  88yo male died at home. Pt's wife called into primary care clinic to inform. Wife did not give information to pt's death. Relevant PMH: Long-term current use of insulin (SCT 71AF- Atrial Fibrillation (SCT 49436004) Ischemic heart disease (SCT 414545008) Loss of sensation (SCT 44077006) Callus (SCT 201040000) Ingrowing nail (SCT 400097005) Peripheral vascular disease (SCT 4000470Adjustment Disorder Unspecified (ICD-9- CM 309.9) Health Maintenance (ICD-9-CM V65.9) CAD (ICD-9-CM 414.9) Benign hypertension (SCT 10725009) Type 2 diabetes mellitus without complication (SCT 313436004) Hyperlipidemia (SCT 55822004) GERD (ICD-9-CM 530.81) Barrett's Esophagus (ICD-9-CM 530.85) Diabetes mellitus (SCT 73211009) Chronic obstructive lung disease (SCT 13Other and unspecified Sleep Apnea (ICD-9-CM 780.57) Hypertrophy (Benign) of Prostate with UrHistoplasmosis (ICD-9-CM 115.90) DJD (ICD-9-CM 715.90) Low back pain (SCT 279039007) Restless Legs (ICD-9-CM 333.94) Colon Polyp (ICD-9-CM 211.3) Rhabdomyolysis (ICD-9-CM 728.88) Tobacco user (ICD-9-CM 305.1) Aneurysm, Aorta, Abdominal (ICD-9-CM 441 Pt had received covid vaccines on 1/16/2021 & on 2/13/2021. Likely pt's death was not related to covid vaccines given pt's advanced age and long time frame between vaccines and date of death.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Swelling face
Clinical narrative: Narrative: after 1 minute patient stated she was having difficulty swallowing. EMS notified. Her face appeared "puffy" benadryl and epi-pen administered VACCINE WAS ADMINISTERED AT ANOTHER FACILITY=patient was treated and EMS to ok to nearby hospital
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Hyponatraemia, Imaging procedure, Intensive care, Laboratory test
Clinical narrative: Narrative:  Pt was a 78 year old male with pmmhx of chronic hyponatremia, CKDIII paroxysmal afib , COPD, HTN, DMII, HLD and chronic anemia presented to the ED via primary care office to "have his gallbladder removed" admitted to MICU for HAGMA 2/2 lactic acidosis and hyponatremia. After imaging and workup, pt was diagnosed with metastatic cancer and discharged with home hospice.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Lactic acidosis, Metabolic acidosis, Metastatic neoplasm
Clinical narrative: Narrative:  Pt was a 78 year old male with pmmhx of chronic hyponatremia, CKDIII paroxysmal afib , COPD, HTN, DMII, HLD and chronic anemia presented to the ED via primary care office to "have his gallbladder removed" admitted to MICU for HAGMA 2/2 lactic acidosis and hyponatremia. After imaging and workup, pt was diagnosed with metastatic cancer and discharged with home hospice.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Blood bicarbonate decreased, Blood fibrinogen, Blood gases abnormal, Blood pH normal
Clinical narrative: Narrative: COVID infection following COVID vaccine serious 01/08, Pfizer, dose #1 01/29 Pfizer, dose #2 08/08 pt cc: fever, rhinorrhea, dyspnea exposure: GOLFING PARTNER 08/09 -- 0902 pt symptoms continue 08/16 COVID swab, result: detected 08/16 CXR impression: CHF versus hazy infiltrates most prominent in the LEFT lower lung. Correlate with clinical scenario. Follow-up recommended. 08/16 pt admit to ED, admit to medicine Cc: SOB dx: ACUTE HYPOIX RESPIRATOR FAILURE 2/2 COVID PNEUMONIA LOS: 14 days 08/16 Troponin I result: <0.016 08/16 PROCALCITONIN result <0.11 08/16 ESR result: 26 08/16 BNP Result: 672 08/16 ABG: I-[H 7.42, iPCO2 28.3, i-PO2 62, i-HCO3 18.2 08/16 DDIMER results: 0.97 08/21 ESR result: 24 08/21 Fibrinogen result: 308 08/21 DDIMER result: 30.29 08/23 PT result: 47.1 08/23 INR Result: 4.21 08/23 DDIMER result: 17.82 08/23 FIBRINOGEN result: 245 08/23 ESR Result: 16 08/24 PT result: 38.1 08/24 INR Result: 3.40 08/24 DDIMER Result: 15.52 08/25 PT Result: 25.2 08/25 DIIMER result: 7.59 08/26 PT Result 24.0 08/26 INR Result 2.14 08/26 DDIMER result 14.096
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Brain natriuretic peptide increased, COVID-19, COVID-19 pneumonia, Cardiac failure congestive, Chest X-ray abnormal
Clinical narrative: Narrative: COVID infection following COVID vaccine serious 01/08, Pfizer, dose #1 01/29 Pfizer, dose #2 08/08 pt cc: fever, rhinorrhea, dyspnea exposure: GOLFING PARTNER 08/09 -- 0902 pt symptoms continue 08/16 COVID swab, result: detected 08/16 CXR impression: CHF versus hazy infiltrates most prominent in the LEFT lower lung. Correlate with clinical scenario. Follow-up recommended. 08/16 pt admit to ED, admit to medicine Cc: SOB dx: ACUTE HYPOIX RESPIRATOR FAILURE 2/2 COVID PNEUMONIA LOS: 14 days 08/16 Troponin I result: <0.016 08/16 PROCALCITONIN result <0.11 08/16 ESR result: 26 08/16 BNP Result: 672 08/16 ABG: I-[H 7.42, iPCO2 28.3, i-PO2 62, i-HCO3 18.2 08/16 DDIMER results: 0.97 08/21 ESR result: 24 08/21 Fibrinogen result: 308 08/21 DDIMER result: 30.29 08/23 PT result: 47.1 08/23 INR Result: 4.21 08/23 DDIMER result: 17.82 08/23 FIBRINOGEN result: 245 08/23 ESR Result: 16 08/24 PT result: 38.1 08/24 INR Result: 3.40 08/24 DDIMER Result: 15.52 08/25 PT Result: 25.2 08/25 DIIMER result: 7.59 08/26 PT Result 24.0 08/26 INR Result 2.14 08/26 DDIMER result 14.096
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Exposure to SARS-CoV-2, Fibrin D dimer, International normalised ratio increased, PCO2 decreased
Clinical narrative: Narrative: COVID infection following COVID vaccine serious 01/08, Pfizer, dose #1 01/29 Pfizer, dose #2 08/08 pt cc: fever, rhinorrhea, dyspnea exposure: GOLFING PARTNER 08/09 -- 0902 pt symptoms continue 08/16 COVID swab, result: detected 08/16 CXR impression: CHF versus hazy infiltrates most prominent in the LEFT lower lung. Correlate with clinical scenario. Follow-up recommended. 08/16 pt admit to ED, admit to medicine Cc: SOB dx: ACUTE HYPOIX RESPIRATOR FAILURE 2/2 COVID PNEUMONIA LOS: 14 days 08/16 Troponin I result: <0.016 08/16 PROCALCITONIN result <0.11 08/16 ESR result: 26 08/16 BNP Result: 672 08/16 ABG: I-[H 7.42, iPCO2 28.3, i-PO2 62, i-HCO3 18.2 08/16 DDIMER results: 0.97 08/21 ESR result: 24 08/21 Fibrinogen result: 308 08/21 DDIMER result: 30.29 08/23 PT result: 47.1 08/23 INR Result: 4.21 08/23 DDIMER result: 17.82 08/23 FIBRINOGEN result: 245 08/23 ESR Result: 16 08/24 PT result: 38.1 08/24 INR Result: 3.40 08/24 DDIMER Result: 15.52 08/25 PT Result: 25.2 08/25 DIIMER result: 7.59 08/26 PT Result 24.0 08/26 INR Result 2.14 08/26 DDIMER result 14.096
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: PO2 decreased, Pneumonia, Procalcitonin, Prothrombin time prolonged, Pyrexia
Clinical narrative: Narrative: COVID infection following COVID vaccine serious 01/08, Pfizer, dose #1 01/29 Pfizer, dose #2 08/08 pt cc: fever, rhinorrhea, dyspnea exposure: GOLFING PARTNER 08/09 -- 0902 pt symptoms continue 08/16 COVID swab, result: detected 08/16 CXR impression: CHF versus hazy infiltrates most prominent in the LEFT lower lung. Correlate with clinical scenario. Follow-up recommended. 08/16 pt admit to ED, admit to medicine Cc: SOB dx: ACUTE HYPOIX RESPIRATOR FAILURE 2/2 COVID PNEUMONIA LOS: 14 days 08/16 Troponin I result: <0.016 08/16 PROCALCITONIN result <0.11 08/16 ESR result: 26 08/16 BNP Result: 672 08/16 ABG: I-[H 7.42, iPCO2 28.3, i-PO2 62, i-HCO3 18.2 08/16 DDIMER results: 0.97 08/21 ESR result: 24 08/21 Fibrinogen result: 308 08/21 DDIMER result: 30.29 08/23 PT result: 47.1 08/23 INR Result: 4.21 08/23 DDIMER result: 17.82 08/23 FIBRINOGEN result: 245 08/23 ESR Result: 16 08/24 PT result: 38.1 08/24 INR Result: 3.40 08/24 DDIMER Result: 15.52 08/25 PT Result: 25.2 08/25 DIIMER result: 7.59 08/26 PT Result 24.0 08/26 INR Result 2.14 08/26 DDIMER result 14.096
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Red blood cell sedimentation rate increased, Rhinorrhoea, SARS-CoV-2 test positive, Troponin I normal
Clinical narrative: Narrative: COVID infection following COVID vaccine serious 01/08, Pfizer, dose #1 01/29 Pfizer, dose #2 08/08 pt cc: fever, rhinorrhea, dyspnea exposure: GOLFING PARTNER 08/09 -- 0902 pt symptoms continue 08/16 COVID swab, result: detected 08/16 CXR impression: CHF versus hazy infiltrates most prominent in the LEFT lower lung. Correlate with clinical scenario. Follow-up recommended. 08/16 pt admit to ED, admit to medicine Cc: SOB dx: ACUTE HYPOIX RESPIRATOR FAILURE 2/2 COVID PNEUMONIA LOS: 14 days 08/16 Troponin I result: <0.016 08/16 PROCALCITONIN result <0.11 08/16 ESR result: 26 08/16 BNP Result: 672 08/16 ABG: I-[H 7.42, iPCO2 28.3, i-PO2 62, i-HCO3 18.2 08/16 DDIMER results: 0.97 08/21 ESR result: 24 08/21 Fibrinogen result: 308 08/21 DDIMER result: 30.29 08/23 PT result: 47.1 08/23 INR Result: 4.21 08/23 DDIMER result: 17.82 08/23 FIBRINOGEN result: 245 08/23 ESR Result: 16 08/24 PT result: 38.1 08/24 INR Result: 3.40 08/24 DDIMER Result: 15.52 08/25 PT Result: 25.2 08/25 DIIMER result: 7.59 08/26 PT Result 24.0 08/26 INR Result 2.14 08/26 DDIMER result 14.096
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death, Road traffic accident
Clinical narrative: Narrative:  Pt was an 84 YO male with PMH significant for dementia, CKD, and gout. Pt was in a severe MVA in May and after discharge from STR pt was transferred to home hospice, where he passed away.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Death, Hepatic cancer, Renal failure
Clinical narrative: Narrative:  65yo died at home on 10/2/2021 after non-agency hospital discharge for failing kidneys. Pt also had active liver cancer. See extensive problem list below. Problem list: CVA Hyperthyroidism CHF Hepatocellular carcinoma with mets to spine, bone, lung Arteriosclerosis aorta Insomnia Splenomegaly Left Ventricular Hypertrophy Tricuspid Valve Regurgitation Left Atrio Enlargement Mitral Valve Regurgitation Diabetic Retinopathy Dilatation of Aorta Hemorrhoid Aortoiliac atherosclerosis Diabetes, on insulin Panniculitis Heart Murmur Sleep Apnea GERD OA Constipation Hypertension Anemia Impairment Hyperlipidemia Cataracts Pt had received covid vaccinations from pharmacy store on 3/3/21 & 3/31/21. Likely this death is not related given patient's age, comorbidities, and long length of time between date of vaccines and date of death.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest pain, Dyspnoea, Haematemesis, Nausea
Clinical narrative: Narrative: c/o SOB + 8/10 CP that radiates up left side of neck. pt unable to give specific time frames of onset of SOB + CP, but thinks they have started on friday after his second covid shot. endorsing nausea with dry heaves at home, in triage he vomtted coffee ground emesis, ~325ml. Breakthrough COVID infection requiring hospitalization
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Neck pain, Pain, Retching, Vaccine breakthrough infection, Vomiting
Clinical narrative: Narrative: c/o SOB + 8/10 CP that radiates up left side of neck. pt unable to give specific time frames of onset of SOB + CP, but thinks they have started on friday after his second covid shot. endorsing nausea with dry heaves at home, in triage he vomtted coffee ground emesis, ~325ml. Breakthrough COVID infection requiring hospitalization
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Narrative:  Acute COVID-19 infection. Hospitalized after completion of Pfizer vaccine series.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood gases, COVID-19, Chest X-ray normal, Diarrhoea, Dyspnoea
Clinical narrative: Narrative: Admission Date: Sep 9,2021 Discharge Date: Sep 22,2021 70 year old male with history of ESRD secondary to HTN s/p renal transplant in 2015 on tacrolimus/prednisone, hx of hepatitis C, DM, prostate cancer s/p XRT, substance abuse (in remission) who presented to the Emergency Department on 09/09/21 with worsening SOB, DOE, and diarrhea in the setting of recent positive Covid-19 test despite being fully vaccinated with Moderna's COVID vaccine 1/4/2021 and 2/1/2021. He was admitted on September 9,2021. ABG on admission 7.49/25/72/19 on FiO2 40% w/ SpO2 96%. He was weaned down to 3L O2 in the ED. CXR without focal airspace consolidation or opacities. Tested positive for Covid-19 on 09/07/21. Received MAB (w/ Regeneron on 09/08/21). Notably upon arrival to the floor, the patient was w/o a supplemental oxygen requirement and was SpO2 >94% on RA. He was treated initially was vancomycin (9/18) and greatly improved clinically; sputum culture grew MRSA, so was transitioned Bactrim; he will finish Doxycycline 9/25/21 for an 8-day course of Abx. Otherwise, he was given supportive care and was eventually discharged on 9/22/2021 to a rehab facility.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea exertional, Fraction of inspired oxygen, SARS-CoV-2 test positive, Sputum culture positive, Staphylococcus test positive
Clinical narrative: Narrative: Admission Date: Sep 9,2021 Discharge Date: Sep 22,2021 70 year old male with history of ESRD secondary to HTN s/p renal transplant in 2015 on tacrolimus/prednisone, hx of hepatitis C, DM, prostate cancer s/p XRT, substance abuse (in remission) who presented to the Emergency Department on 09/09/21 with worsening SOB, DOE, and diarrhea in the setting of recent positive Covid-19 test despite being fully vaccinated with Moderna's COVID vaccine 1/4/2021 and 2/1/2021. He was admitted on September 9,2021. ABG on admission 7.49/25/72/19 on FiO2 40% w/ SpO2 96%. He was weaned down to 3L O2 in the ED. CXR without focal airspace consolidation or opacities. Tested positive for Covid-19 on 09/07/21. Received MAB (w/ Regeneron on 09/08/21). Notably upon arrival to the floor, the patient was w/o a supplemental oxygen requirement and was SpO2 >94% on RA. He was treated initially was vancomycin (9/18) and greatly improved clinically; sputum culture grew MRSA, so was transitioned Bactrim; he will finish Doxycycline 9/25/21 for an 8-day course of Abx. Otherwise, he was given supportive care and was eventually discharged on 9/22/2021 to a rehab facility.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, Anticoagulant therapy, Bundle branch block right, COVID-19
Clinical narrative: Narrative: 78-year-old male with past medical history of SVT, history of pulmonary embolus on 5 years ago not on long-term anticoagulation, prostate cancer status post radiation, BPH, hyperlipidemia, GERD admitted to the hospital on 7/14/2021 for hip acute hypoxic respiratory failure secondary to COVID-19 infection. Pt received both doses of pfizer vaccine. Patient last transferred to ICU on 7/16/2021 morning for increased oxygen requirement. Chest x-ray on 7/22/2021 showed increased airspace opacity bilaterally more prominent at periphery of left midlung. Patient is status post remdesiver, Decadron but was not a candidate for Tocilizumab as CRP was 4.3. Patient had an episode of pleuritic chest pain on 7/25/2021, negative troponin and positive D-dimer and found to have a provoked submassive pulmonary embolism. Filling defect also noted in left upper lung and left lower lung. Nonspecific right ventricular prominence and CTA. EKG incomplete right bundle branch block with signs of right ventricular strain. proBNP 256 and PESI Class V. Echo on 7/26/2021 showed normal right ventricular function with trace regurg and no gross deformity. Patient currently on anticoagulation apixaban and was switched from Lovenox but patient was not on any chronic anticoagulation even with a prior episode of pulmonary emboli in 2015. Patient was okay for discharge by respiratory therapist and physical therapist and  is currently on 4.5 L nasal cannula.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Echocardiogram abnormal, Electrocardiogram ST-T segment abnormal, Electrocardiogram abnormal, Fibrin D dimer increased
Clinical narrative: Narrative: 78-year-old male with past medical history of SVT, history of pulmonary embolus on 5 years ago not on long-term anticoagulation, prostate cancer status post radiation, BPH, hyperlipidemia, GERD admitted to the hospital on 7/14/2021 for hip acute hypoxic respiratory failure secondary to COVID-19 infection. Pt received both doses of pfizer vaccine. Patient last transferred to ICU on 7/16/2021 morning for increased oxygen requirement. Chest x-ray on 7/22/2021 showed increased airspace opacity bilaterally more prominent at periphery of left midlung. Patient is status post remdesiver, Decadron but was not a candidate for Tocilizumab as CRP was 4.3. Patient had an episode of pleuritic chest pain on 7/25/2021, negative troponin and positive D-dimer and found to have a provoked submassive pulmonary embolism. Filling defect also noted in left upper lung and left lower lung. Nonspecific right ventricular prominence and CTA. EKG incomplete right bundle branch block with signs of right ventricular strain. proBNP 256 and PESI Class V. Echo on 7/26/2021 showed normal right ventricular function with trace regurg and no gross deformity. Patient currently on anticoagulation apixaban and was switched from Lovenox but patient was not on any chronic anticoagulation even with a prior episode of pulmonary emboli in 2015. Patient was okay for discharge by respiratory therapist and physical therapist and  is currently on 4.5 L nasal cannula.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Intensive care, Lung opacity, Pleuritic pain, Prohormone brain natriuretic peptide increased, Pulmonary embolism
Clinical narrative: Narrative: 78-year-old male with past medical history of SVT, history of pulmonary embolus on 5 years ago not on long-term anticoagulation, prostate cancer status post radiation, BPH, hyperlipidemia, GERD admitted to the hospital on 7/14/2021 for hip acute hypoxic respiratory failure secondary to COVID-19 infection. Pt received both doses of pfizer vaccine. Patient last transferred to ICU on 7/16/2021 morning for increased oxygen requirement. Chest x-ray on 7/22/2021 showed increased airspace opacity bilaterally more prominent at periphery of left midlung. Patient is status post remdesiver, Decadron but was not a candidate for Tocilizumab as CRP was 4.3. Patient had an episode of pleuritic chest pain on 7/25/2021, negative troponin and positive D-dimer and found to have a provoked submassive pulmonary embolism. Filling defect also noted in left upper lung and left lower lung. Nonspecific right ventricular prominence and CTA. EKG incomplete right bundle branch block with signs of right ventricular strain. proBNP 256 and PESI Class V. Echo on 7/26/2021 showed normal right ventricular function with trace regurg and no gross deformity. Patient currently on anticoagulation apixaban and was switched from Lovenox but patient was not on any chronic anticoagulation even with a prior episode of pulmonary emboli in 2015. Patient was okay for discharge by respiratory therapist and physical therapist and  is currently on 4.5 L nasal cannula.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Regurgitation, Troponin normal
Clinical narrative: Narrative: 78-year-old male with past medical history of SVT, history of pulmonary embolus on 5 years ago not on long-term anticoagulation, prostate cancer status post radiation, BPH, hyperlipidemia, GERD admitted to the hospital on 7/14/2021 for hip acute hypoxic respiratory failure secondary to COVID-19 infection. Pt received both doses of pfizer vaccine. Patient last transferred to ICU on 7/16/2021 morning for increased oxygen requirement. Chest x-ray on 7/22/2021 showed increased airspace opacity bilaterally more prominent at periphery of left midlung. Patient is status post remdesiver, Decadron but was not a candidate for Tocilizumab as CRP was 4.3. Patient had an episode of pleuritic chest pain on 7/25/2021, negative troponin and positive D-dimer and found to have a provoked submassive pulmonary embolism. Filling defect also noted in left upper lung and left lower lung. Nonspecific right ventricular prominence and CTA. EKG incomplete right bundle branch block with signs of right ventricular strain. proBNP 256 and PESI Class V. Echo on 7/26/2021 showed normal right ventricular function with trace regurg and no gross deformity. Patient currently on anticoagulation apixaban and was switched from Lovenox but patient was not on any chronic anticoagulation even with a prior episode of pulmonary emboli in 2015. Patient was okay for discharge by respiratory therapist and physical therapist and  is currently on 4.5 L nasal cannula.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  63yo patient with mental health issues and homelessness, chronic hepatitis, htn, gi reflux,carcinoma of prostate, anxiety, depression, ADHD was found deceased in the street by law enforcement on 9/17/2021. Pt had received covid vaccines from the agency on 2/24/2021 & 3/24/2021. Likely death is not related to vaccines given pt's issues surrounding his death and given long timeframe between date covid vaccines given & date of death.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Narrative:
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Blood glucose increased, Computerised tomogram thorax normal, Culture wound positive, Erythema
Clinical narrative: Narrative:  09/03 COVID vaccine dose #1 of 1 in right deltoid 09/07 Pt developed pain and swelling to right axillary area 09/08 Pt reports area has become more swollen, more painful, and red 09/10 Pt developed fever of 100.5 09/11 Pt seen in ED, axillary described as 7cm x 7cm area of induration, mildly tender, 2cm area of erythema and fluctuance on top, mild-moderate surrounding erythema and calor; CT chest WNL, discharged from ED with rx for keflex and bactrim 09/14 Pt returns to ED c/o increased pain and worsening swelling, sharp axillary pain with movement; incision and drainage in ED with purulent discharge, pt admitted for obs; given clindamycin 900mg iv, continued to clindamycin po; wound culture grew MRSA 09/20 Discharged from hospital with home health for wound care and Bactrim po x 14 days
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Glycosylated haemoglobin increased, Incisional drainage, Oedema peripheral, Pain, Purulent discharge
Clinical narrative: Narrative:  09/03 COVID vaccine dose #1 of 1 in right deltoid 09/07 Pt developed pain and swelling to right axillary area 09/08 Pt reports area has become more swollen, more painful, and red 09/10 Pt developed fever of 100.5 09/11 Pt seen in ED, axillary described as 7cm x 7cm area of induration, mildly tender, 2cm area of erythema and fluctuance on top, mild-moderate surrounding erythema and calor; CT chest WNL, discharged from ED with rx for keflex and bactrim 09/14 Pt returns to ED c/o increased pain and worsening swelling, sharp axillary pain with movement; incision and drainage in ED with purulent discharge, pt admitted for obs; given clindamycin 900mg iv, continued to clindamycin po; wound culture grew MRSA 09/20 Discharged from hospital with home health for wound care and Bactrim po x 14 days
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Skin induration, Staphylococcus test positive, Tenderness, White blood cell count increased
Clinical narrative: Narrative:  09/03 COVID vaccine dose #1 of 1 in right deltoid 09/07 Pt developed pain and swelling to right axillary area 09/08 Pt reports area has become more swollen, more painful, and red 09/10 Pt developed fever of 100.5 09/11 Pt seen in ED, axillary described as 7cm x 7cm area of induration, mildly tender, 2cm area of erythema and fluctuance on top, mild-moderate surrounding erythema and calor; CT chest WNL, discharged from ED with rx for keflex and bactrim 09/14 Pt returns to ED c/o increased pain and worsening swelling, sharp axillary pain with movement; incision and drainage in ED with purulent discharge, pt admitted for obs; given clindamycin 900mg iv, continued to clindamycin po; wound culture grew MRSA 09/20 Discharged from hospital with home health for wound care and Bactrim po x 14 days